Evaluation of a Gastroenteritis Severity Score for Use in Outpatient Settings

Abstract

The MVS seems to measure effectively the global severity of disease in a cohort of children with acute gastroenteritis. These data support the use of the MVS as an outcome measure in future clinical trials.

vAetiology of Diarrhoea in Children Under Five in Zambia Detected Using Luminex xTAG Gastrointestinal Pathogen Panel

“…Moderate-to-severe diarrhoea: Using modified Vesikari score components [14], we defined moderate-to-severe diarrhoea as a score ≥ 9. The modified Vesikari score had seven components namely: diarrhoea duration, maximal number of diarrhoeal stools per 24 hour period, vomiting duration, maximal number of vomiting episodes per 24 hour period, maximal recorded fever, health care provider visits, and treatment.…”

First description of gastroenteritis viruses in Lebanese children: A pilot study

“…Severe acute gastroenteritis was defined according to the modified Vesikari score (MVS ≥11) [10]. Patients with chronic diarrhea or who had documented history of non-infectious etiology of diarrhea and vomiting, and patients with bloody diarrhea were excluded from this study.…”

Etiological Spectrum of Acute Gastroenteritis in Children Less Than 5 Years of Age with Special Reference to Norovirus

“…Co-infection of norovirus with rotavirus was seen in two cases and from one case three viruses namely rotavirus, adenovirus and astrovirus were isolated. As per modified vesikari score (6) rotavirus gastroenteritis was more severe as compared to norovirus.…”